NEW YORK, United States, May 04, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Cell-Based Assays Market By Product & Service (Reagents, Cell Lines, Instrument & Software, Assay Kits, Microplate, And Services), By Application (Basic Research And Drug Discovery), By End-Use (Pharmaceutical & Biotech Companies, Academic & Research Institutes, And CROs), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.
“According to the latest research study, the demand of global Cell-Based Assays Market size & share in terms of revenue was valued at USD 16.3 billion in 2022 and it is expected to surpass around USD 26.5 billion mark by 2030, growing at a compound annual growth rate (CAGR) of approximately 12.4% during the forecast period 2023 to 2030.”
What is Cell-Based Assays? How big is the Cell-Based Assays Industry?
Report Overview:
Cell-based assays assist in monitoring the effectiveness of compounds in a cellular environment. This, in turn, is key in understanding compound behaviors in a biological ecosystem and bringing into line data with a translatable biomarker. Cellular assays are finding a plethora of applications in biomedical and drug-discovery testing activities.
This will help in effectively determining toxicity, biological activities, biochemical equipment, and off-target interactions. The advantage of making utilization of cell-based assays are the generation of complicated and biologically relevant data. Unlike conventional biochemical assays, cell-based assays are physiologically relevant and can determine complicated properties simultaneously.
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.zionmarketresearch.com/sample/cell-based-assays-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2023 updated report.
- About 219+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2023
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Zion Market Research Methodology
Global Cell-Based Assays Market: Growth Factors
Pharma & biotech companies and CROs are making utility of cell-based assays for detecting and optimizing methods in drug discovery methods. This, in turn, will help in carving a favorable growth curve for the cell-based assays market across the globe. The manufacturing price of biopharmaceuticals has increased to a major extent and hence healthcare professional including hospitals & clinics are likely to adopt the use of cell-based assays. This will prompt the expansion of the global market trends.
Nevertheless, huge device costs and low usage of reagents can hinder the global cell-based assays industry expansion in the forecasting years. In addition to this, massive costs of maintaining equipment used in biotech research and an increase in indirect spending as well as a surge in the overall costs of ownership of devices can further decimate the industry growth across the globe. Increase in the investments for research & development activities related to biotech & pharma sectors will open new facets of growth for the global industry.
Directly Purchase a copy of the report with TOC @ https://www.zionmarketresearch.com/buynow/su/cell-based-assays-market
Report Scope
| Report Attribute | Details |
| Market Size in 2022 | USD 16.3 Billion |
| Projected Market Size in 2030 | USD 26.5 Billion |
| CAGR Growth Rate | 12.4% CAGR |
| Base Year | 2022 |
| Forecast Years | 2023-2030 |
| Key Market Players | F. Hoffmann-La Roche Ltd. (Roche Holdings AG), BD, Promega Corp., Bio-Rad Laboratories, Inc., Merck KGaA, Corning Inc., Charles River Laboratories, Lonza AG, Danaher Corp., and Thermo Fisher Scientific Inc. |
| Key Segment | By Product & Service, Application, End-Use, and Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
| Purchase Options | Request customized purchase options to meet your research needs. Explore purchase options |
Cell-Based Assays Market: Segmentation Analysis
The global cell-based assays market is divided into application, product, end-use, and region.
The application segment of the cell-based assays market is segmented into reagents, cell lines, instrument & software, assay kits, microplate, and services segments. Moreover, the assay kits segment, which led the application space in 2022, is set to maintain its segmental dominance even in the foreseeable future. The segmental expansion in the coming years can be owing to its large-scale use in the biopharmaceutical industry.
On the basis of product, the cell-based assays industry across the globe is bifurcated into basic research and drug discovery segments. The drug discovery segment, which led the application landscape in 2022, is projected to contribute to a major industry share in the forecasting years. The upsurge of the segment in the next couple of years can be subject to the strong demand for new therapeutic drugs including generic ones for effective treatment of a spectrum of ailments across the globe. The scaling up of the drug discovery segment can be due to a prominent increment in the number of FDA approvals of newly launched drugs which also include generic drugs.
Based on the end-use, cell-based assays across the globe is sectored into academic & research institutes, pharmaceutical & biotech companies, and CROs segments. Moreover, the academic & research institutes segment, which contributed lucratively towards the global market share in 2022, is anticipated to register the highest CAGR over the next eight years. The expansion of the segment in the next couple of years can be ascribed to an increase in the acceptance of these cell-based assays in biotech research & development ventures as well as the devising of new assay-based diagnostics. Apart from this, Moreover, cell-based assays assist in research in the oncology, stem cells, and immunology domains.
The global Cell-Based Assays market is segmented as follows:
By Product & Service
- Reagents
- Cell Lines
- Instrument & Software
- Assay Kits
- Microplate
- Services
By Application
- Basic Research
- Drug Discovery
By End-Use
- Pharmaceutical & Biotech Companies
- Academic & Research Institutes
- CROs
Browse the full “Cell-Based Assays Market By Product & Service (Reagents, Cell Lines, Instrument & Software, Assay Kits, Microplate, and Services), By Application (Basic Research and Drug Discovery), By End-Use (Pharmaceutical & Biotech Companies, Academic & Research Institutes, and CROs), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030.” Report at https://www.zionmarketresearch.com/report/cell-based-assays-market
Competitive Landscape
Some of the main competitors dominating the global Cell-Based Assays market include -
- Charles River Laboratories
- F. Hoffmann-La Roche Ltd. (Roche Holdings AG)
- BD
- Promega Corp.
- Merck KGaA
- Corning Inc.
- Bio-Rad Laboratories Inc.
- Lonza AG
- Danaher Corp.
Key Insights from Primary Research:
- According to the analysis shared by our research forecaster, the Cell-Based Assays market is likely to expand at a CAGR of around 12.4% during the forecast period (2023-2030).
- In terms of revenue, the Cell-Based Assays market size was valued at around US$ 16.3 billion in 2022 and is projected to reach US$ 26.5 billion by 2030.
- The global market is anticipated to record massive growth over the forecast period owing to the use of cell-based assays in the drug development process.
- Based on product & service, the assay kits segment is predicted to contribute majorly towards the market growth over the forecast timeline.
- In terms of application, the drug discovery segment is projected to account for a major share of the global market in 2023-2030.
- On the basis of the end-use, the pharmaceutical & biotech companies’ segment is projected to account for a major share of the global market in 2023-2030.
- Region-wise, the Asia-Pacific cell-based assay market is projected to register the fastest CAGR during the assessment period.
Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/cell-based-assays-market
Key questions answered in this report:
- What is the market size and growth rate forecast for Cell-Based Assays industry?
- What are the main driving factors propelling the Cell-Based Assays Market forward?
- What are the leading companies in the Cell-Based Assays Industry?
- What segments does the Cell-Based Assays Market cover?
- How can I receive a free copy of the Cell-Based Assays Market sample report and company profiles?
Key Offerings:
- Market Size & Forecast by Revenue | 2023−2030
- Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
- Market Segmentation – A detailed analysis By Product & Service, Application, End-Use, and Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Request for Customization on this Report as per your requirements - https://www.zionmarketresearch.com/custom/1022
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
Regional Analysis:
North America, which contributed to more than two-fifths of the global cell-based assays market share in 2022, is expected to establish a number one position in the global market over the estimated timeline. The regional market upsurge from 2023 to 2030 can be owing to extensive research on medical products in the U.S. and Canada. Apparently, the presence of well-known academic research organizations as well as pharmaceutical industries in North America will account sizably for the regional market size.
By Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- France
- UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Recent Developments
- In the second quarter of 2020, PhenoVista Biosciences, a U.S.-based CRO firm in the in-vitro cell-based assays sector, entered into a strategic collaboration with Olympus Corporation, a Japanese firm manufacturing reprography & optics items, for providing 3D cell-based assay services for drug discovery procedures. The strategic move is predicted to spur the expansion of the cell-based assays market globally.
- In the second half of 2022, Life Net Health Lifesciences, a key organization offering new human cell & tissue-based solutions for biomedical research to develop next-gen treatments, launched cell-based assays including biocompatibility assays and cytotoxicity screening tests. The move will contribute lucratively towards the growth of the cell-based assays industry proceeds in the years ahead.
- In the first half of 2022, Beckman Coulter Life Sciences, a major Danaher company highlighting providing healthcare services, launched the Aquios STEM system which provides a new solution for stem cell research. The initiative is likely to benefit the cell-based assays market growth across the globe in the upcoming years.
To know an additional revised 2023 list of market players, request a brochure of the report: https://www.zionmarketresearch.com/requestbrochure/cell-based-assays-market
Browse Other Related Research Reports from Zion Market Research:
- Plasma Therapy Market: https://www.zionmarketresearch.com/report/plasma-therapy-market
- Cell Expansion Market: https://www.zionmarketresearch.com/report/cell-expansion-market
- CRISPR Genome Editing Market: https://www.zionmarketresearch.com/report/crispr-genome-editing-market
- Cancer Biomarkers Market: https://www.zionmarketresearch.com/report/cancer-biomarkers-market
- Glycobiology/Glycomics Market: https://www.zionmarketresearch.com/report/glycomics-glycobiology-industry
- Immunofluorescence Assay Market: https://www.zionmarketresearch.com/report/immunofluorescence-assay-market
About Zion Market Research:
Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/zion-market-research/
Follow Us on Twitter: https://twitter.com/zion_research
Follow Us on Facebook: https://www.facebook.com/zionmarketresearch
Follow Us on Pinterest: https://www.pinterest.com/zionmarketresearch/
Follow Us on YouTube: https://youtu.be/Y0Yfi7N8zSs
Contact Us:
Rushikesh Dorge
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 7768 006 007
Web: https://www.zionmarketresearch.com/
Blog: https://zmrblog.com/
Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?
Email Directly Here with Detail Information: sales@zionmarketresearch.com
